Dianne C Daniel

Title: Dianne C Daniel: Innovator in Synthetic Peptide Research

Introduction

Dianne C Daniel is a prominent inventor based in Norfolk, VA (US). She has made significant contributions to the field of synthetic polynucleotide-binding peptides. Her work focuses on developing novel peptides that have the potential to revolutionize cancer treatment and genetic modulation.

Latest Patents

Dianne holds a patent for a "Family of synthetic polynucleotide-binding peptides and uses thereof." This invention provides novel synthetic peptides, including the TZIP peptide, which serve as oncogenic and genetic modulators. These peptides are particularly useful for inhibiting the proliferation of cancer cells characterized by amplified c-MYC genes. The invention outlines methods for therapeutic uses of these peptides in treating various cancers, including small cell lung carcinoma, prostate cancer, lymphoma, brain tumors, colon cancer, bladder cancer, acute myeloid leukemia (AML), malignant melanoma, mesothelioma, and cancers of the head and neck. Additionally, the peptides are beneficial in the treatment and prevention of HIV transmission and in addressing expanded nucleotide repeat diseases, including certain currently untreatable and debilitating conditions.

Career Highlights

Dianne is affiliated with Eastern Virginia Medical School, where she continues her research and development in synthetic peptides. Her work has garnered attention for its potential impact on cancer therapies and genetic research.

Collaborations

Dianne collaborates with Edward M Johnson, contributing to advancements in her field through shared expertise and innovative research.

Conclusion

Dianne C Daniel's contributions to synthetic peptide research highlight her role as an innovator in the medical field. Her patented work has the potential to significantly impact cancer treatment and genetic modulation, showcasing the importance of her research in advancing healthcare solutions.